Skip to content
Open access

Nomogram for predicting post-percutaneous coronary intervention restenosis in patients with coronary artery disease and diabetes: a retrospective study

Oct 2026 · PeerJ · Vol 14 · 0 citations · 42 references
Medicine

TL;DR

Key predictive factors for post-PCI restenosis in CAD patients with DM through case-control analysis were identified and the nomogram model showed good discrimination on internal bootstrap validation, and may provide a useful exploratory tool to support risk stratification and inform management aimed at reducing the restenosis burden in high-risk cardiovascular populations.

Abstract

Background Coronary artery disease (CAD) combined with diabetes mellitus (DM) significantly increases the risk of vascular restenosis following percutaneous coronary intervention (PCI). Despite advancements in stent technology, restenosis remains a concern, especially in diabetic patients. This study aims to predict restenosis risk using serum metabolites and risk factors. Methods A retrospective analysis was conducted on 272 CAD and type 2 diabetes mellitus (T2DM) patients who underwent PCI between January 2020 and June 2023. Based on one-year angiographic follow-up, patients were divided into restenosis (n = 121) and non-restenosis groups (n = 151). Serum metabolites and biomarkers, including glycated hemoglobin (HbA1c), insulin-like growth factor I (IGF-I), low-density lipoprotein cholesterol (LDL-C), tumor necrosis factor-α (TNF-α), and high-sensitivity C-reactive protein (hsCRP), were evaluated, together with procedure-related characteristics (including stent type and post-procedural percentage diameter stenosis) and medication use (including calcium antagonists). Logistic regression and correlation analysis identified significant predictors, and a nomogram prediction model was developed and internally validated using bootstrap resampling. Results Lower HbA1c levels were associated with restenosis (rho = −0.142, P = 0.008; OR = 0.767, 95% CI [0.625–0.941]). Higher levels of IGF-I (rho = 0.328, P < 0.001; OR = 1.053, 95% CI [1.032–1.075]), LDL-C (r = 0.135, P = 0.025; OR = 1.682, 95% CI [1.107–2.555]), TNF-α (r = 0.172, P = 0.004; OR = 1.434, 95% CI [1.119–1.838]), and hsCRP (r = 0.179, P = 0.003; OR = 1.786, 95% CI [1.185–2.693]) were also significantly associated. Non-drug-eluting stents (DES) and higher percentage diameter stenosis (%DS) increased restenosis risk. Calcium antagonists use was negatively correlated with restenosis (r = − 0.185, P = 0.002; OR = 0.449, 95% CI [0.228–0.884]). The nomogram model demonstrated good discrimination for restenosis (apparent AUC = 0.833; bootstrap-corrected AUC = 0.808). Conclusion This study identified key predictive factors for post-PCI restenosis in CAD patients with DM through case-control analysis. The nomogram model showed good discrimination on internal bootstrap validation. Pending external validation, it may provide a useful exploratory tool to support risk stratification and inform management aimed at reducing the restenosis burden in high-risk cardiovascular populations.

Read PDF

Similar papers

Open access Sep 2026

Lipoprotein(a)-to-HDL-C ratio and risk of repeat revascularization and in-stent restenosis after PCI in patients with chronic coronary syndrome undergoing follow-up coronary imaging.

It is suggested that LHR may serve as a complementary lipid-related marker for long-term risk stratification in this population of patients with chronic coronary syndrome after percutaneous coronary intervention (PCI).

Jia-Le Wang, Long-Cheng Liu, Pei-Pei Lu et al. · 0 citations
Open access Oct 2026

Prognostic value of twelve systemic inflammatory indices for composite cardiovascular events in chronic coronary syndrome patients with or without diabetes undergoing PCI

In diabetic patients with CCS, inflammatory indices such as SII, NLR, and PAR are strong predictors of PCI-related complications, including RR and ISR, and may serve as practical tools for risk stratification.

L. Liu, W.-J.-L. Wang, M. Lihong · 0 citations
Open access Oct 2026

Inflammatory and insulin resistance indicators for predicting in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention

The C-Reactive protein-triglyceride glucose index(CTI), a reliable surrogate indicator of inflammatory and insulin resistance, is independently associated with coronary artery disease of various clinical manifestations. This study aimed to investigate the prognostic value of the CTI index in predicting in-stent r...

Jia-Le Wang, Long-Cheng Liu, Pei-Pei Lu et al. · 0 citations
Open access Oct 2026

Remnant cholesterol and residual cardiovascular risk in diabetic patients undergoing coronary revascularization: insights from a nationwide ohort

Remnant cholesterol (remnant-C) is an emerging contributor to residual cardiovascular risk, particularly in patients with diabetes mellitus (DM). To evaluate the prognostic impact of remnant-C levels in diabetic patients who underwent percutaneous coronary intervention (PCI) or coronary artery bypass graft...

H. Jeon, H. Kim, S. Kim et al. · 0 citations
Open access Sep 2026

Hemoglobin glycation index and prognosis after successful chronic total occlusion percutaneous coronary intervention: a retrospective cohort study

Elevated HGI was independently and linearly associated with heightened long-term adverse clinical outcomes after successful CTO-PCI and suggest that HGI may have potential as a prognostic marker for risk stratification in this population; however, prospective validation is required before clinical application.

Song Wen, Ze-Han Huang, Ling-Bing Meng et al. · 0 citations
Open access Oct 2026

Risk factors for post-PCI restenosis in patients with coronary heart disease and the development and validation of a nomogram prediction model

This study aimed to analyze risk factors for in-stent restenosis (ISR) following percutaneous coronary intervention (PCI) in patients with coronary heart disease and develop and validate a nomogram prediction model. Clinical data were retrospectively collected from 1135 patients with coronary heart disease who underwen...

Xi-Na Jin, Zhen Dong, Dong-Sheng Chai · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.